130 related articles for article (PubMed ID: 18478224)
1. Flow-induced permeation of non-occlusive blood clots: an MRI study and modelling.
Grobelnik B; Vidmar J; Tratar G; Blinc A; Sersa I
Eur Biophys J; 2008 Sep; 37(7):1229-33. PubMed ID: 18478224
[TBL] [Abstract][Full Text] [Related]
2. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
3. Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots.
Sersa I; Vidmar J; Grobelnik B; Mikac U; Tratar G; Blinc A
Phys Med Biol; 2007 Jun; 52(11):2969-85. PubMed ID: 17505083
[TBL] [Abstract][Full Text] [Related]
4. Whole blood clot dissolution: in vitro study on the effects of permeation pressure.
Jeong WW; Jang AS; Rhee K
Proc Inst Mech Eng H; 2007 May; 221(4):357-63. PubMed ID: 17605393
[TBL] [Abstract][Full Text] [Related]
5. A mathematical model for the dissolution of non-occlusive blood clots in fast tangential blood flow.
Sersa I; Tratar G; Mikac U; Blinc A
Biorheology; 2007; 44(1):1-16. PubMed ID: 17502685
[TBL] [Abstract][Full Text] [Related]
6. Blood clot dissolution dynamics simulation during thrombolytic therapy.
Sersa I; Tratar G; Blinc A
J Chem Inf Model; 2005; 45(6):1686-90. PubMed ID: 16309274
[TBL] [Abstract][Full Text] [Related]
7. Flow through clots determines the rate and pattern of fibrinolysis.
Blinc A; Kennedy SD; Bryant RG; Marder VJ; Francis CW
Thromb Haemost; 1994 Feb; 71(2):230-5. PubMed ID: 8191404
[TBL] [Abstract][Full Text] [Related]
8. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
[TBL] [Abstract][Full Text] [Related]
9. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.
Wang SS; Chou NK; Chung TW
J Biomed Mater Res A; 2009 Dec; 91(3):753-61. PubMed ID: 19051299
[TBL] [Abstract][Full Text] [Related]
10. Analysis of blood clot degradation fragment sizes in relation to plasma flow velocity.
Bajd F; Vidmar J; Blinc A; Serša I
Gen Physiol Biophys; 2012 Sep; 31(3):237-45. PubMed ID: 23047936
[TBL] [Abstract][Full Text] [Related]
11. Dependence of blood clot lysis on the mode of transport of urokinase into the clot--a magnetic resonance imaging study in vitro.
Blinc A; Planinsic G; Keber D; Jarh O; Lahajnar G; Zidansĕk A; Demsar F
Thromb Haemost; 1991 May; 65(5):549-52. PubMed ID: 1871717
[TBL] [Abstract][Full Text] [Related]
12. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
Niessen F; Hilger T; Hoehn M; Hossmann KA
Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion.
Anand S; Kudallur V; Pitman EB; Diamond SL
Ann Biomed Eng; 1997; 25(6):964-74. PubMed ID: 9395042
[TBL] [Abstract][Full Text] [Related]
14. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
Wu JH; Siddiqui K; Diamond SL
Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
[TBL] [Abstract][Full Text] [Related]
15. Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow.
Piebalgs A; Xu XY
J R Soc Interface; 2015 Dec; 12(113):20150949. PubMed ID: 26655469
[TBL] [Abstract][Full Text] [Related]
16. No effect of clot age or thrombolysis on argatroban's inhibition of thrombin.
Hantgan RR; Jerome WG; Hursting MJ
Blood; 1998 Sep; 92(6):2064-74. PubMed ID: 9731064
[TBL] [Abstract][Full Text] [Related]
17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
18. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.
Anand S; Diamond SL
Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700
[TBL] [Abstract][Full Text] [Related]
19. The influence of transport parameters and enzyme kinetics of the fibrinolytic system on thrombolysis: mathematical modelling of two idealised cases.
Zidansek A; Blinc A
Thromb Haemost; 1991 May; 65(5):553-9. PubMed ID: 1831302
[TBL] [Abstract][Full Text] [Related]
20. Engineering design of optimal strategies for blood clot dissolution.
Diamond SL
Annu Rev Biomed Eng; 1999; 1():427-62. PubMed ID: 11701496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
